22 May 2013
Keywords: competition, mevalotin, weak, home, market, hit, sankyo
Article | 28 February 2005
For the first three quarters (April-December 2004) of the fiscal year to March 2005, turnover and operating income at Japanese drug major ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
28 February 2005
21 May 2013
© 2013 thepharmaletter.com